DSD-C022

46,XY DSD · 46,XY · DSD-C022

DSD-C022 · 46,XY DSD · 2026

Genes NR5A1 · Karyotype 46,XY · Phenotypes HPO:0000135, Hypogonadism (HP:0000135)

Growth parameters showed a height of 164 cm (+1.5 SD), weight of 75 kg (>+2 SD), and body mass index of 28.2 kg/m², consistent with overweight, based on female reference growth charts (

Images · 1

Case fields and evidence

Category

46,XY DSD

Age

Not reported

Sex

Not reported

Karyotype

46,XY

Genetics

NR5A1

Phenotypes

Hypogonadism (HP:0000135)

Diagnosis

Growth parameters showed a height of 164 cm (+1.5 SD), weight of 75 kg (>+2 SD), and body mass index of 28.2 kg/m², consistent with overweight, based on female reference growth charts (

Follow-up

Height and weight growth curves showing accelerated growth velocity during follow-up. Management and follow-up Management was discussed in a multidisciplinary setting involving pediatric endocrinologists, pediatric surgeons, geneticists, and psychologists. Estrogen replacement therapy with 17β-estradiol was subsequently initiated, along with management of hyperandrogenism and regular endocrinological follow-up

General phenotype

A 12-year-and-6-month-old phenotypic female adolescent, born to parents reported as non- consanguineous based on family history, was referred for evaluation of progressive virilization. Physical examination revealed a female phenotype with severe hirsutism characterized by coarse, pigmented terminal hair involving the face, upper and lower limbs, and abdomen. Genetic analysis Cytogenetic analysis revealed a 46,XY karyotype, confirming discordance between chromosomal and phenotypic sex

Imaging

Radiological findings Abdominopelvic ultrasound demonstrated a complete absence of the uterus and ovaries. Abdominopelvic magnetic resonance imaging (MRI) demonstrated a small intervesicorectal structure deviated to the right, measuring approximately 22 mm in its greatest dimension, compatible with a Müllerian remnant

Laboratory findings

Not reported

Management

Estrogen replacement therapy with 17β-estradiol was subsequently initiated, along with management of hyperandrogenism and regular endocrinological follow-up

Pathology

Surgical and histopathological findings Bilateral gonadal exploration with biopsy was performed

Genetic variants

c.871-2A>G

Evidence level

See source

Clinical history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | 46,XY DSD · 46,XY · DSD-C022 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C022?version=v1.4.0